Sermorelin vs mk677: how the two actually compare

Last updated 2026-07-24

what are sermorelin and mk-677, and how are they different

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), the first 29 amino acids of the natural 44-amino-acid hormone. It binds to GHRH receptors on the pituitary gland and tells your body to make and release its own growth hormone. It was FDA approved under the brand name Geref for diagnosing growth hormone deficiency and for treating it in children, though the manufacturer discontinued the branded product for business reasons, not because of a safety recall. That's a meaningful distinction: Geref left the market, it wasn't pulled for causing harm. MK-677 (ibutamoren) is a completely different class of molecule. It's a ghrelin receptor agonist taken as a pill, meaning it mimics the hunger hormone ghrelin to stimulate growth hormone release through a separate pathway in the pituitary and hypothalamus. It has never been approved by the FDA for any human use ^[1]. It shows up in research studies on muscle wasting and frailty, in supplement products marketed for bodybuilding, and on gray-market peptide sites, but there's no approved drug product and no established medical dosing standard. The short version: sermorelin has a regulatory history and a defined clinical use case. MK-677 doesn't. That gap matters more than most comparison articles admit, because it affects sourcing, oversight, and what you can reasonably expect a prescriber to support. If you want the deeper background on how sermorelin works and what the evidence actually shows, see sermorelin.

how do sermorelin and mk-677 raise growth hormone differently

Both compounds raise growth hormone (GH) levels, but they hit different receptors and produce different downstream effects, which is why lumping them together as "GH boosters" is misleading. Sermorelin acts on the GHRH receptor. This is the same receptor natural GHRH from the hypothalamus uses. Because sermorelin still depends on a functioning pituitary and still respects the body's natural pulsatile release pattern and negative feedback loops, it tends to produce a more physiologic GH pulse rather than a flat, sustained elevation ^[2]. MK-677 acts on the ghrelin receptor (GHS-R1a). It stimulates GH release through a separate mechanism and also has appetite-stimulating effects, since ghrelin is the hormone that drives hunger. Clinical studies of MK-677 have shown it reliably raises GH and IGF-1 levels over weeks of dosing, including a 2-year randomized trial in older adults that found sustained increases in GH and IGF-1 ^[3]. But that same ghrelin-pathway activity is tied to some of its more common side effects: increased appetite, water retention, and measurable increases in fasting blood glucose and reductions in insulin sensitivity in some trial participants ^[3]. Neither drug is HGH itself. Both are "secretagogues," meaning they provoke your own pituitary to release growth hormone rather than supplying synthetic HGH directly. That's the core similarity. The mechanism split (GHRH-receptor vs ghrelin-receptor) is the core difference, and it explains most of the divergence in side effect profile below.

sermorelin vs mk-677: side-by-side comparison

is mk-677 legal, and is sermorelin legal

Sermorelin requires a prescription in the United States. It's compounded by licensed pharmacies under a prescriber's order, typically for off-label adult use since the original pediatric-indicated brand (Geref) is no longer marketed. Compounding pharmacies operate under FDA and state board of pharmacy oversight, which means batch testing, sterility standards, and a paper trail back to a licensed prescriber. MK-677 sits in a legal gray zone. It's not a controlled substance, so possession generally isn't criminalized, but it's also not an approved drug or a lawful dietary supplement ingredient. The FDA has taken enforcement action against companies marketing unapproved growth hormone secretagogues as supplements; in 2020 it sent a warning letter to a supplement marketer over MK-677 products, and products sold as "research chemicals not for human consumption" are a common workaround sellers use to avoid drug regulation ^[1]. Buying it means buying from a supplement company or peptide vendor with no prescriber involved, no standardized dosing, and no guarantee of what's actually in the vial or capsule. Worth noting: the World Anti-Doping Agency lists ibutamoren as a prohibited substance for competitive athletes ^[6]. Sermorelin's GHRH class is also on WADA's prohibited list, so neither is a legal shortcut for anyone drug-tested in sport.

which is safer, sermorelin or mk-677

Sermorelin's safety data comes from decades-old FDA trials for Geref plus a smaller body of modern off-label prescribing experience. Reported side effects in the original labeling were mostly local and mild: injection site reactions, flushing, headache, and occasional dizziness. Because sermorelin respects the body's own feedback loops, if GH and IGF-1 rise too high, the pituitary's own regulatory mechanisms tend to pull back, which limits how far things can drift from normal. MK-677's safety picture is more mixed. A 2-year randomized, placebo-controlled trial in adults over 60 (published in Annals of Internal Medicine, PMID 18711154) found sustained increases in GH and IGF-1, but also found more participants on MK-677 developed increased fasting glucose and reduced insulin sensitivity compared to placebo, along with more reports of fluid retention and joint pain ^[3]. A separate trial in hip fracture patients over age 65 found no significant improvement in physical recovery despite raising IGF-1 levels ^[5], which is a useful reminder that raising a hormone number doesn't automatically translate into a functional benefit. Neither drug has long-term safety data past a few years. If you want the honest rundown on what's actually known (and not known) about extended sermorelin use, see sermorelin long-term side effects.

how does sermorelin compare to real hgh (somatropin)

This is the question most readers actually care about, so it deserves a straight answer instead of marketing spin. HGH (somatropin) is synthetic human growth hormone itself, injected directly. It bypasses the pituitary entirely and raises GH and IGF-1 levels directly and predictably, which is why it's FDA approved for confirmed growth hormone deficiency, certain wasting syndromes, and a small list of other specific conditions ^[7]. Because it delivers a fixed dose regardless of what your body would naturally produce, it can push GH and IGF-1 above normal physiologic patterns if not carefully dosed and monitored, and it carries a longer, better documented list of side effects at supraphysiologic doses, including joint pain, fluid retention, carpal tunnel symptoms, and in some populations increased insulin resistance ^[7]. Sermorelin is weaker by design, and that's not a flaw, it's the mechanism. It can only prompt the pituitary to release GH if the pituitary is still capable of responding. In someone with primary pituitary failure or significant pituitary damage, sermorelin will do little or nothing, and HGH replacement is the only option that works. In someone with an intact but underactive GH axis (which describes most adults being evaluated for age-related GH decline), sermorelin produces a more modest, more physiologic rise in GH, generally with a gentler side effect profile and a lower ceiling on how far things can go wrong. So the honest comparison isn't "sermorelin is better" or "HGH is better." It's that they serve different problems. HGH is the stronger, more direct tool for confirmed deficiency. Sermorelin is the gentler, self-limiting option for people whose pituitary still works, and it's the one that's actually being prescribed off-label through telehealth and anti-aging clinics right now, because it doesn't require the same intensity of monitoring that direct HGH replacement does. Neither is approved or evidenced for anti-aging, muscle building, or athletic performance in healthy adults, no matter how it's marketed.

how are sermorelin and mk-677 dosed

Sermorelin, when prescribed, is typically injected subcutaneously once daily, usually at night before bed, to work with the body's natural nocturnal GH pulse. The original Geref label for pediatric growth hormone deficiency specified doses around 0.2-0.3 mg/day at bedtime. Adult off-label protocols used by prescribers vary and aren't standardized the way an FDA-approved adult indication would be, which is exactly why individualized prescribing and monitoring matters. For a detailed breakdown of typical dosing ranges and how prescribers think about titration, see sermorelin dosage chart and the sermorelin dosage calculator. MK-677 doses used in published research trials have ranged from about 10 mg to 25 mg once daily by mouth ^{[3] [4]}. Because it's not an approved drug, there's no FDA-set dosing standard, no official titration schedule, and no requirement that products sold online match what was actually studied. Supplement-market MK-677 products have been found in independent testing to vary meaningfully in actual content versus label claims, which is a known problem across the unregulated peptide and "research chemical" market generally.

does mk-677 or sermorelin build more muscle or burn more fat

Neither compound has strong human evidence for muscle building or fat loss in healthy adults, and claims to the contrary usually outrun the data. MK-677's own research base is mostly in specific clinical populations: older adults, people recovering from hip fracture, patients with wasting conditions. The 2-year trial in older adults found increases in fat-free mass alongside GH and IGF-1 increases, but also flagged the glucose and fluid retention issues above, and the trial wasn't designed or marketed as a bodybuilding study ^[3]. The hip fracture recovery trial found IGF-1 went up but functional recovery didn't meaningfully improve ^[5], which is a caution against assuming a hormone increase equals a real-world benefit. Sermorelin's evidence base for body composition changes in adults without diagnosed GH deficiency is thin. Most of its trial history comes from pediatric growth hormone deficiency diagnosis and treatment, not adult muscle or fat outcomes. Prescribers who use it off-label in adults are generally working from GH-axis physiology and smaller studies, not large randomized trials targeting body composition as the primary endpoint. If a seller promises noticeable muscle gain or fat loss from either compound within a few weeks, treat that as a marketing claim, not a clinical one.

how do you get sermorelin or mk-677 legitimately

Sermorelin requires bloodwork, a prescriber's evaluation, and a prescription filled through a licensed compounding pharmacy. That process exists specifically to catch the people for whom this isn't appropriate (active pituitary tumors, certain cancers, pregnancy) and to make sure dosing is matched to labs and symptoms rather than guessed at. If you're checking on where legitimate access is available, sermorelin peptide near me covers how the prescribing and pharmacy pathway typically works, and sermorelin reviews covers what people report after actually using it under medical supervision. MK-677 has no equivalent legitimate medical pathway in the US right now. There's no FDA-approved product, so there's no prescription to get. Anyone buying it is buying an unregulated substance from a supplement brand or peptide vendor, with no pharmacy-level quality control and no prescriber checking labs or medical history first. That doesn't automatically mean every product is contaminated or mislabeled, but it does mean the buyer is absorbing all of the verification risk that a pharmacy and prescriber would normally handle. Worth being blunt about this: at Sermorelin Co, we point readers toward the provider-reviewed prescription route, filled through a licensed compounding pharmacy, precisely because that's the pathway with actual oversight. We don't manufacture or compound anything ourselves; we connect the medical evaluation to the pharmacy that does.

sermorelin vs mk-677: which one should you actually consider

If you want a compound with an actual FDA history, a prescription pathway, pharmacy-level quality control, and a side effect profile that's mild and mostly local (injection site reactions, occasional flushing or headache), sermorelin is the more conservative and better-documented choice ^[2]. If you're drawn to MK-677 because it's a pill instead of a shot, understand what you're trading for that convenience: no FDA oversight, no standardized product, documented fasting glucose and insulin sensitivity changes in the best available trial, and a gray legal and quality-control status ^{[1] [3]}. Some people tolerate it fine. Some don't, and won't know until they've been taking an unregulated product for weeks. Neither is a substitute for medically supervised HGH in someone with confirmed, lab-diagnosed growth hormone deficiency. And neither should be started without bloodwork and a conversation with a prescriber who can look at your actual IGF-1, glucose, and pituitary function, more than a marketing page.

Frequently asked questions

Is mk-677 the same as sermorelin?

No. Sermorelin is a GHRH analog injected subcutaneously that acts on GHRH receptors. MK-677 is an oral ghrelin receptor agonist. They raise growth hormone through different pathways, have different side effect profiles, and sermorelin has FDA regulatory history (as Geref) while MK-677 has never been FDA approved for any use.

Which is safer, sermorelin or mk-677?

Sermorelin's documented side effects (from its FDA-approved Geref history) are mostly mild and local: injection site reactions, flushing, headache. MK-677's best clinical trial found increased fasting glucose, reduced insulin sensitivity, and fluid retention in some participants over 2 years. Sermorelin also has pharmacy-level quality oversight that MK-677, as an unregulated product, generally lacks.

Is mk-677 legal in the United States?

It's not a controlled substance, so possession isn't typically criminalized, but it's also not FDA-approved as a drug or legal dietary supplement ingredient. It's sold as a "research chemical," which is a common label sellers use to skirt drug regulation. Competitive athletes should also know WADA prohibits ibutamoren.

Was sermorelin taken off the market for safety reasons?

No. The branded product Geref was discontinued by its manufacturer for business reasons, not pulled by the FDA for a safety issue. Sermorelin itself is still legally available today through compounding pharmacies with a valid prescription; it's the original branded version that's no longer manufactured.

Does mk-677 raise blood sugar?

Trial data suggests it can. A 2-year randomized trial in adults over 60 found participants taking MK-677 had greater increases in fasting glucose and reduced insulin sensitivity compared to placebo. Anyone with diabetes risk factors should discuss this specifically before considering it.

Can sermorelin replace HGH treatment?

Only if the pituitary still works. Sermorelin stimulates the pituitary to make its own growth hormone, so it's ineffective in people with primary pituitary failure or significant pituitary damage; those individuals need direct HGH replacement. In people with an intact but underactive GH axis, sermorelin can produce a real, if more modest, increase in GH.

How is sermorelin taken versus mk-677?

Sermorelin is given as a subcutaneous injection, typically once daily at bedtime to match the body's natural GH pulse. MK-677 is taken orally, usually once daily, because its roughly 24-hour half-life doesn't require timing around a nocturnal pulse the way sermorelin's short half-life does.

Does mk-677 build muscle better than sermorelin?

Neither has strong evidence for muscle building in healthy adults. MK-677 trials in older or frail populations show increases in fat-free mass alongside GH and IGF-1 increases, but functional recovery outcomes haven't consistently improved. Sermorelin's evidence base is mostly diagnostic and pediatric, not adult body composition.

Why is sermorelin prescription-only but mk-677 isn't regulated the same way?

Sermorelin has an actual FDA drug history (as Geref), which keeps it under prescription and compounding pharmacy oversight even though the branded product is discontinued. MK-677 was never approved as a drug, so it falls into the unregulated "research chemical" and supplement market instead of the prescription pharmaceutical system.

What's the typical mk-677 dose used in studies?

Published trials have used roughly 10 to 25 mg once daily by mouth. There's no FDA-set standard dose since it's not an approved drug, and products sold commercially aren't guaranteed to match what was actually used in research, since testing has found label-versus-content mismatches in the unregulated peptide market.

Does either sermorelin or mk-677 have long-term safety data?

Not really, beyond a few years. The longest MK-677 trial ran 2 years. Sermorelin's original trials supporting Geref were shorter and focused on pediatric growth hormone deficiency. Long-term data in healthy adults using either off-label doesn't currently exist in solid form.

Can you buy sermorelin without a prescription like mk-677?

Not legally in the way MK-677 is commonly sold. Sermorelin requires a prescription and is dispensed through a licensed compounding pharmacy. Some gray-market sellers offer it without a prescription, but that bypasses the medical evaluation and pharmacy oversight that make it a meaningfully safer option than MK-677 in the first place.

Sources

1. FDA warning letter, American Cellular Labs Inc. (marketing MK-677/ibutamoren products), issued January 6, 2020: MK-677/ibutamoren is not FDA approved for human use and has been the subject of FDA enforcement action against marketers
2. NCBI Bookshelf, StatPearls: Sermorelin: Sermorelin acts on the GHRH receptor and has a short half-life of roughly 10-20 minutes
3. Nass R, et al. Annals of Internal Medicine, 2008, PMID 18711154: A 2-year randomized trial found sustained GH/IGF-1 increases with MK-677 along with increased fasting glucose, reduced insulin sensitivity, and fluid retention
4. Copinschi G, et al. pharmacokinetics of oral MK-677 in healthy adults, PMID 8968554: MK-677 has an approximate 24-hour half-life and has been studied at oral doses of roughly 10-25 mg/day
5. Adunsky A, et al. MK-677 in hip fracture recovery trial, PMID 21811670: A trial in older adults recovering from hip fracture found MK-677 raised IGF-1 without significantly improving functional recovery
6. World Anti-Doping Agency, Prohibited List: Ibutamoren (MK-677) and GHRH analogs are listed as prohibited substances for competitive athletes
7. FDA-approved prescribing information, Genotropin (somatropin), NDA 020280: Somatropin (synthetic HGH) is FDA approved for confirmed growth hormone deficiency and specific wasting conditions, with a documented side effect profile including fluid retention and insulin resistance at high doses